GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 0874.HK
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Friday for Guangzhou Baiyunshan Pharmaceutical
(Updated on Apr 19, 2024)

Buy candidate since Apr 18, 2024 Gain 0.74% PDF

The Guangzhou Baiyunshan Pharmaceutical stock price gained 0.743% on the last trading day (Friday, 19th Apr 2024), rising from HK$20.20 to HK$20.35. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.49% from a day low at HK$20.05 to a day high of HK$20.55. The price has risen in 9 of the last 10 days and is up by 10.12% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 600 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately HK$29.76 million.

The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Guangzhou Baiyunshan Pharmaceutical stock with a 90% probability to be traded between HK$18.36 and HK$21.54 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

0874.HK Signals & Forecast

Mostly positive signals in the chart today. The Guangzhou Baiyunshan Pharmaceutical stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at HK$19.82 and HK$20.12. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, April 05, 2024, and so far it has risen 10.12%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Guangzhou Baiyunshan Pharmaceutical stock

Guangzhou Baiyunshan Pharmaceutical finds support from accumulated volume at HK$20.10 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved HK$0.500 (2.49%) between high and low. For the last week, the stock has had daily average volatility of 2.13%.

Our recommended stop-loss: HK$19.61 (-3.66%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 10 days ago.)

Trading Expectations (0874.HK) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited to open at HK$20.32, and during the day (based on 14 day Average True Range), to move between HK$19.88 and HK$20.82, which gives a possible trading interval of +/-HK$0.472 (+/-2.32%) up or down from last closing price. If Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited takes out the full calculated possible swing range there will be an estimated 4.64% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at HK$20.50 (0.74%) than the support at HK$20.10 (1.23%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Guangzhou Baiyunshan Pharmaceutical stock to perform well in the short-term period.

Current score: 3.453 Buy Candidate Unchanged

Predicted Opening Price for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
HK$20.32 ( 0.164%) HK$20.35

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 0874.HK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 20.82 2.29 %
R2 20.63 1.35 %
R1 20.51 0.775 %
Current price: 20.35
Support S1 20.13 -1.10 %
S2 20.01 -1.68 %
S3 19.82 -2.62 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 21.70 6.63 %
R2 21.20 4.18 %
R1 20.50 0.737 %
Current price 20.35
Support S1 20.10 -1.23%
S2 19.96 -1.92%
S3 19.24 -5.45%

0874 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 14, 2023 Jun 14, 2023 Jun 14, 2023 HK$0.81 3.36%
2 Jun 10, 2022 Jun 10, 2022 Jun 10, 2022 HK$0.81 3.67%
3 Jun 21, 2021 Jun 21, 2021 Jun 21, 2021 HK$0.655 3.06%
4 Jul 15, 2020 Jul 15, 2020 Jul 15, 2020 HK$0.645 2.71%
5 Jul 15, 2019 Jul 15, 2019 Jul 15, 2019 HK$0.483 1.35%

FAQ

What is the symbol for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock and on which exchange is it traded?
The symbol for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is 0874.HK and it is traded on the HKEX (Hong Kong Stock Exchange).

Should I buy or sell Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock?
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Guangzhou Baiyunshan Pharmaceutical stock to perform well in the short-term period.

How to buy Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock.

What's the current price of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock?
As of the end of day on the 2024-04-19, the price of an Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK) share was HK$20.35.

What is the 52-week high and low for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock?
The 52-week high for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock is HK$27.70 and the 52-week low is HK$18.48.

What is the market capitalization of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock?
As of the 2024-04-19, the market capitalization of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is 50.636B.
Click to get the best stock tips daily for free!

About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through four segments: Great Southern TCM, Great Commerce, Great Health, and ... 0874.HK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT